NO166133C - Analogifremgangsmaate for fremstilling av ((bis(aryl)metylen)-1-piperidinyl)-alkylpyrimidinoner. - Google Patents

Analogifremgangsmaate for fremstilling av ((bis(aryl)metylen)-1-piperidinyl)-alkylpyrimidinoner.

Info

Publication number
NO166133C
NO166133C NO833956A NO833956A NO166133C NO 166133 C NO166133 C NO 166133C NO 833956 A NO833956 A NO 833956A NO 833956 A NO833956 A NO 833956A NO 166133 C NO166133 C NO 166133C
Authority
NO
Norway
Prior art keywords
alkylpyrimidinones
piperidinyl
aryl
bis
methyl
Prior art date
Application number
NO833956A
Other languages
English (en)
Norwegian (no)
Other versions
NO166133B (no
NO833956L (no
Inventor
Ludo Edmond Josephine Kennis
Jan Vandenberk
Josephus Carolus Mertens
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO833956L publication Critical patent/NO833956L/no
Publication of NO166133B publication Critical patent/NO166133B/no
Publication of NO166133C publication Critical patent/NO166133C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
NO833956A 1982-11-01 1983-10-31 Analogifremgangsmaate for fremstilling av ((bis(aryl)metylen)-1-piperidinyl)-alkylpyrimidinoner. NO166133C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43807982A 1982-11-01 1982-11-01
US06/517,612 US4485107A (en) 1982-11-01 1983-07-27 [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones

Publications (3)

Publication Number Publication Date
NO833956L NO833956L (no) 1984-05-02
NO166133B NO166133B (no) 1991-02-25
NO166133C true NO166133C (no) 1991-06-05

Family

ID=27031541

Family Applications (1)

Application Number Title Priority Date Filing Date
NO833956A NO166133C (no) 1982-11-01 1983-10-31 Analogifremgangsmaate for fremstilling av ((bis(aryl)metylen)-1-piperidinyl)-alkylpyrimidinoner.

Country Status (26)

Country Link
US (1) US4485107A (bg)
EP (1) EP0110435B1 (bg)
KR (1) KR870000825B1 (bg)
AU (1) AU559176B2 (bg)
BG (2) BG51158A3 (bg)
CA (1) CA1211438A (bg)
CS (1) CS238396B2 (bg)
CY (1) CY1607A (bg)
DE (1) DE3378825D1 (bg)
DK (1) DK168919B1 (bg)
ES (1) ES8601965A1 (bg)
FI (1) FI77868C (bg)
GR (1) GR81277B (bg)
HK (1) HK52691A (bg)
IE (1) IE56180B1 (bg)
IL (1) IL70094A0 (bg)
IN (1) IN159576B (bg)
MA (1) MA19941A1 (bg)
NO (1) NO166133C (bg)
NZ (1) NZ205993A (bg)
PH (1) PH20483A (bg)
PT (1) PT77493B (bg)
RO (1) RO86698B (bg)
SG (1) SG46791G (bg)
SU (1) SU1313349A3 (bg)
ZW (1) ZW23283A1 (bg)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4529727A (en) * 1982-04-21 1985-07-16 Janssen Pharmaceutical, N.V. Pyrimido[2,1-b][1,3]-thiazines
US4581171A (en) * 1983-07-27 1986-04-08 Janssen Pharmaceutica, N.V. [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones useful for treating psychotropic disorders
US4533665A (en) * 1983-07-27 1985-08-06 Janssen Pharmaceutica [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones
US4888426A (en) * 1983-11-30 1989-12-19 Janssen Pharmaceutica N.V. 1-(5-methyl-furan-2-ylmethyl)-N-(4-piperidinyl)imidazo [4,5-6]pyridine-2-amine
US4695569A (en) * 1983-11-30 1987-09-22 Janssen Pharmaceutica N.V. Bicyclic heterocyclyl containing N-(bicyclic heterocyclyl)-4-piperidinamines
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
US4874766A (en) * 1986-09-22 1989-10-17 Janssen Pharmaceutica N.V. Method of promoting wound-healing
US4921854A (en) * 1986-12-30 1990-05-01 Egis Gyogyszergyar Condensed thiazolopyrimidine, pyrimido-thiazine or thiazepine pyrimidine compounds
DE3738844A1 (de) * 1987-11-16 1989-05-24 Merck Patent Gmbh Analgetikum
IL90858A (en) * 1988-07-07 1994-08-26 Rhone Poulenc Sante History (Aza) Naftalensultam, their preparation and preparations containing them
IL90879A0 (en) * 1988-09-02 1990-02-09 Janssen Pharmaceutica Nv 3-piperidinyl-indazole derivatives,their preparation and antihypertensive compositions containing them
US5158952A (en) * 1988-11-07 1992-10-27 Janssen Pharmaceutica N.V. 3-[2-[4-(6-fluoro-1,2-benzisoxozol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9 tetrahydro-9-hydroxy-2-methyl-4H-pyrido [1,2-a]pyrimidin-4-one, compositions and method of use
GB8900382D0 (en) * 1989-01-09 1989-03-08 Janssen Pharmaceutica Nv 2-aminopyrimidinone derivatives
US5256659A (en) * 1989-01-09 1993-10-26 Janssen Pharmaceutica N.V. 2-aminopyrimidinone derivatives
US5140029A (en) * 1989-01-09 1992-08-18 Janssen Pharmaceutica N.V. 2-aminopyrimidinone derivatives
FR2643373B1 (fr) * 1989-01-10 1993-12-31 Adir Cie Nouveaux derives des bisarylalcenes, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
GB9008850D0 (en) * 1990-04-19 1990-06-13 Janssen Pharmaceutica Nv Novel 2,9-disubstituted-4h-pyridol(1,2-a)pyrimidin-4-ones
ES2050069B1 (es) * 1992-07-10 1994-12-16 Vita Invest Sa Procedimiento para la obtencion de 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-il)piperidino)etil)-2-metil-6,7,8,9-tetrahidro-4h-pirido(1,2-a) pirimidin-4-ona.
PL314481A1 (en) 1993-11-19 1996-09-16 Janssen Pharmaceutica Nv Microencapsulated substituted 3-piperidinyl 1,2-benzoisoxazoles and 1,2-benzoisothiazoles
ZA979781B (en) * 1996-11-14 1998-06-08 Akzo Nobel Nv Piperidine derivatives.
UA72189C2 (uk) 1997-11-17 2005-02-15 Янссен Фармацевтика Н.В. Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
UA75051C2 (en) 1999-09-03 2006-03-15 Syngenta Participations Ag Tetrahydropiridines as pesticides, a composition, a method for the preparation thereof and a method of controlling pests
TW200400005A (en) * 2002-02-11 2004-01-01 Syngenta Participations Ag Derivatives of (1-benzyl-piperidine-4-yl)-diphenyl-methanol
KR20040034996A (ko) * 2002-10-18 2004-04-29 한미약품 주식회사 리스페리돈의 개선된 제조방법
CN100384421C (zh) * 2002-12-18 2008-04-30 拜尔农科股份公司 N-(取代的芳基甲基)-4-(二取代的甲基)哌啶和吡啶
WO2004094415A1 (en) * 2003-04-22 2004-11-04 Synthon B.V. Risperidone monohydrochloride
NZ580495A (en) 2007-04-13 2011-05-27 Southern Res Inst Use of anti-angiogenic agents and methods of use, particulary amiodarone for inhibiting or reducing angiogenesis
EP3231793B1 (en) * 2014-12-12 2020-03-11 Japan Tobacco Inc. Dihydropyrimidine-2-one compounds and medicinal uses thereof
PE20210550A1 (es) 2018-02-28 2021-03-17 Japan Tobacco Inc Compuestos de 4-metildihidropirimidinona y su uso farmaceutico
CN112724070B (zh) * 2021-01-08 2022-11-25 南京方生和医药科技有限公司 一种α，α-二苯基-4-哌啶甲醇的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1252315A (bg) * 1969-06-05 1971-11-03
US3960863A (en) * 1974-06-25 1976-06-01 Sankyo Company Limited Pyrido[1,2-a]pyrimidinone derivatives
DE3000923A1 (de) * 1979-01-17 1980-07-31 Degussa Neue n-alkoxy-dithienylpiperidine
US4342870A (en) * 1980-03-28 1982-08-03 Janssen Pharmaceutica N.V. Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives
US4443451A (en) * 1981-07-15 1984-04-17 Janssen Pharmaceutica N.V. Bicyclic pyrimidin-5-one derivatives

Also Published As

Publication number Publication date
DK498483A (da) 1984-05-02
BG51158A3 (bg) 1993-02-15
FI77868B (fi) 1989-01-31
KR870000825B1 (ko) 1987-04-23
CY1607A (en) 1992-04-03
IN159576B (bg) 1987-05-30
FI77868C (fi) 1989-05-10
PH20483A (en) 1987-01-16
BG60538B2 (bg) 1995-07-28
CA1211438A (en) 1986-09-16
HK52691A (en) 1991-07-19
FI833995A0 (fi) 1983-10-31
US4485107A (en) 1984-11-27
RO86698B (ro) 1985-05-02
PT77493A (en) 1983-11-01
IE56180B1 (en) 1991-05-08
ZW23283A1 (en) 1985-05-22
AU2083483A (en) 1984-05-10
NO166133B (no) 1991-02-25
DK168919B1 (da) 1994-07-11
EP0110435B1 (en) 1989-01-04
EP0110435A1 (en) 1984-06-13
IL70094A0 (en) 1984-01-31
CS238396B2 (en) 1985-11-13
DK498483D0 (da) 1983-10-31
RO86698A (ro) 1985-04-17
AU559176B2 (en) 1987-02-26
NZ205993A (en) 1986-06-11
IE832540L (en) 1984-05-01
PT77493B (en) 1986-05-28
ES526868A0 (es) 1985-11-01
DE3378825D1 (de) 1989-02-09
KR850000462A (ko) 1985-02-27
NO833956L (no) 1984-05-02
FI833995A (fi) 1984-05-02
CS766383A2 (en) 1984-12-14
ES8601965A1 (es) 1985-11-01
SU1313349A3 (ru) 1987-05-23
GR81277B (bg) 1984-12-11
SG46791G (en) 1991-07-26
MA19941A1 (fr) 1984-07-01

Similar Documents

Publication Publication Date Title
NO166133C (no) Analogifremgangsmaate for fremstilling av ((bis(aryl)metylen)-1-piperidinyl)-alkylpyrimidinoner.
NO158461C (no) Analogifremgangsmaate for fremstilling av fenyl-piperidin-propanol-derivater.
NO164712C (no) Analogifremgangsmaate til fremstilling av metylendifosfonsyre-derivater.
NO163668C (no) Fremgangsmaate for fremstilling av immunogent kompleks.
NO813726L (no) Fremgangsmaate for fremstilling av piperazinyl-benzo-heterocykliske forbindelser
DK157876C (da) Analogifremgangsmaade til fremstilling af imidazo-rifamycin-derivater
DK155282C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater
DK149949C (da) Analogifremgangsmaade til fremstilling af n-aryl-piperazinalkanamider
NO162158C (no) Fremgangsmaate for fremstilling av polyolefiner.
DK157680C (da) Analogifremgangsmaade til fremstilling af indolderivater
NO159667C (no) Fremgangsmaate for fremstilling av kikhostetoksid.
DK162524C (da) Analogifremgangsmaade til fremstilling af 5-alkylthio-tetrazolderivater
NO823326L (no) Fremgangsmaate for fremstilling av cykliske dihydroksyforbindelser
DK150903C (da) Analogifremgangsmaade til fremstilling af benzisoselenazoloner
DK159824C (da) Analogifremgangsmaade til fremstilling af succinylferroproteiner
NO814065L (no) Fremgansmaate for fremstilling av imidazolylfenylamidiner
DK162167C (da) Analogifremgangsmaade til fremstilling af mitosanderivater
DK75592A (da) Analogifremgangsmaade til fremstilling af platin-diamin komplekser
NO812519L (no) Fremgangsmaate for fremstilling av kolesterase.
NO833531L (no) Fremgangsmaate for fremstilling av 7-substituerte-3-vinyl-3-cefem-forbindelser
NO160000C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive forbindelser.
NO813814L (no) Fremgangsmaate for fremstilling av monoalkyletere av hydrokinonforbindelser
NO162018C (no) Fremgangsmaate for fremstilling av 4-metyl-5-alkyltiometylimidazoler.
DK42284D0 (da) Fremgangsmaade til fraktionering af phosphatider
DK151956C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater